ProfileGDS4718 / 239013_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 43% 66% 39% 32% 50% 43% 38% 34% 41% 34% 33% 38% 42% 39% 46% 40% 47% 42% 36% 44% 36% 36% 44% 37% 43% 41% 52% 31% 43% 36% 47% 31% 42% 38% 47% 38% 35% 34% 67% 35% 45% 39% 48% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1894144
GSM549102patient 115, normal, homogenized [OPG study]5.1754243
GSM549104patient 119, normal, homogenized [OPG study]6.5585266
GSM549108patient 138, normal, homogenized [OPG study]5.0174339
GSM549119patient 077, normal, homogenized [OPG study]4.6231132
GSM549133patient 032, cancer, homogenized [OPG study]5.4384550
GSM549139patient 042, cancer, homogenized [OPG study]5.1336143
GSM549099patient 107, normal, homogenized [OPG study]4.9279738
GSM549109patient 139, normal, homogenized [OPG study]4.7515334
GSM549110patient 046, normal, homogenized [OPG study]5.0556141
GSM549114patient 063, normal, homogenized [OPG study]4.6890734
GSM549122patient 082, normal, homogenized [OPG study]4.667833
GSM549134patient 033, cancer, homogenized [OPG study]4.8728838
GSM549136patient 036, cancer, homogenized [OPG study]5.0124942
GSM549140patient 044, cancer, homogenized [OPG study]4.9253639
GSM549111patient 047, normal, homogenized [OPG study]5.2542546
GSM549113patient 057, normal, homogenized [OPG study]4.9194940
GSM549132patient 031, cancer, homogenized [OPG study]5.3378247
GSM549137patient 038, cancer, homogenized [OPG study]5.079642
GSM549142patient 047, cancer, homogenized [OPG study]4.9166736
GSM549100patient 110, normal, homogenized [OPG study]5.1990644
GSM549107patient 135, normal, homogenized [OPG study]4.779736
GSM549115patient 068, normal, homogenized [OPG study]4.727836
GSM549116patient 072, normal, homogenized [OPG study]5.1666344
GSM549120patient 078, normal, homogenized [OPG study]4.8662837
GSM549131patient 030, cancer, homogenized [OPG study]5.0829343
GSM549118patient 074, normal, homogenized [OPG study]5.0397841
GSM549129patient 027, cancer, homogenized [OPG study]5.6566352
GSM549123patient 088, normal, homogenized [OPG study]4.5713331
GSM549124patient 006, cancer, homogenized [OPG study]5.1582443
GSM549126patient 015, cancer, homogenized [OPG study]4.7758436
GSM549128patient 025, cancer, homogenized [OPG study]5.3370547
GSM549103patient 117, normal, homogenized [OPG study]4.6169531
GSM549117patient 073, normal, homogenized [OPG study]5.0634642
GSM549138patient 041, cancer, homogenized [OPG study]4.877538
GSM549141patient 045, cancer, homogenized [OPG study]5.2994347
GSM549130patient 028, cancer, homogenized [OPG study]4.8794638
GSM549101patient 111, normal, homogenized [OPG study]4.796535
GSM549105patient 128, normal, homogenized [OPG study]4.7498634
GSM549106patient 134, normal, homogenized [OPG study]6.6360867
GSM549112patient 048, normal, homogenized [OPG study]4.7648335
GSM549125patient 011, cancer, homogenized [OPG study]5.2546645
GSM549127patient 024, cancer, homogenized [OPG study]4.9172539
GSM549135patient 035, cancer, homogenized [OPG study]5.3702748